DNA Biomed Solns (DNA) — Cash Flow Reinvestment Rate
Latest as of December 2022:
0.00x
DNA Biomed Solns (DNA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting ILA0.00 (capex ILA0.00 ) from operating cash flow of ILA394.50K. See DNA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
ILA0.00
Capex + Investments
Operating Cash Flow
ILA394.50K
ILA
Capital Expenditures
ILA0.00
ILA
DNA Biomed Solns Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for DNA Biomed Solns across 1 annual periods. For the full cash flow conversion analysis, see DNA Biomed Solns operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for DNA Biomed Solns (2024–2024)
Year-by-year capital reinvestment analysis for DNA Biomed Solns. See DNA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.00x | ILA0.00 | ILA1.61 Million | ILA0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow